◆ 会议时间:2026年10月14-17日
◆ 会议地点:荷兰 马斯特里赫特
◆ 会议简介:
2026年第22届欧洲免疫缺陷学会(ESID)双年会议将于2026年10月14-17日在荷兰马斯特里赫特举行。
届欧洲免疫缺陷学会(ESID)是一个于1994年成立的非营利性组织。ESID致力于通过鼓励研究、开发教育项目和促进所有参与这些疾病的诊断、治疗和管理的人员之间的合作来提高原发性免疫缺陷(PID)领域的知识水平。(未经许可禁止复制摘录转载本站任何内容-领域国际医学会议网-lingyuint.com)。
22nd Biennial Meeting of the European Society for Immunodeficiencies (ESID 2026)
Date: 14-17 October 2026,
Venue: Maastricht, The Netherlands
Dear Colleagues and Friends,
We sincerely hope that this message finds you well.
We are delighted to invite you to the 22nd biennial ESID Meeting to be held 14-17 October 2026, in Maastricht, the Netherlands. Maastricht is a city where history meets innovation and where heritage meets science. The local and international scientific committees will gather an exciting programme to make this event very special.
The theme for the meeting will be “Translational Immunology beyond boundaries”. With this theme we will show the interaction between basic science and clinical research, between immunology and other areas of research. We wish to stimulate the interaction between junior and senior scientists and between patients, nurses and doctors. We will bring together internationally renowned scientists and clinicians to present and discuss major and the newest developments in inborn errors of immunity, through keynote lectures, symposia, educational workshops, interactive sessions, poster presentations, and meet-the-expert sessions.
As usual, the first day of the meeting will offer an educational programme with high quality educational lectures and interactive sessions, which will not only be of great benefit to students and trainees, but also to established clinicians and scientists interested in up-to-date insights into pathogenesis, recognition and management of inborn errors of immunity.
We are looking forward to welcoming you to the beautiful city of Maastricht, for an inspiring meeting bringing you the latest advances in the field.
With our best wishes,
Fabio Candotti
ESID President
Mirjam van der Burg
ESID 2026 Meeting Chair
◆ 参会对象:医生、医院科室主任/副主任、住院医师、医院管理者、医护人员以及从事该领域研究的科学家、研究人员、医药企业代表等等。
|